ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,011Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 46

$555K Total Retail Price of All Prescriptions

Rank: 7 out of 46

653 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 653 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 653 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

5% of this provider’s 10,562 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 544 519 1 4
FUROSEMIDE 455 440 2 7
CEPHALEXIN 409 362 3 38
HYDROCODONE-ACETAMINOPHEN 356 281 S3 4 1
LISINOPRIL 309 279 5 3
SIMVASTATIN 275 232 6 6
AMLODIPINE BESYLATE 232 215 7 8
TRAMADOL HCL 218 193 8 16
PROMETHAZINE HCL 211 175 R 9 40
CITALOPRAM HBR 207 191 10 23
METFORMIN HCL 206 165 11 9
OMEPRAZOLE 199 192 12 5
CIPROFLOXACIN HCL 197 178 13 46
TAMSULOSIN HCL 185 185 14 25
NAMENDA 158 158 15 24
DONEPEZIL HCL 155 155 16 19
AZITHROMYCIN 145 127 17 30
HYDROCHLOROTHIAZIDE 140 102 18 14
KLOR-CON M20 133 131 19 58
METOPROLOL TARTRATE 128 97 20 10
ALENDRONATE SODIUM 117 117 21 28
METOPROLOL SUCCINATE 113 94 22 17
PANTOPRAZOLE SODIUM 111 99 23 52
SERTRALINE HCL 106 95 24 22
ESCITALOPRAM OXALATE 105 93 25 49
WARFARIN SODIUM 104 89 26 13
HYDROXYZINE HCL 102 98 R 27 114
CLOPIDOGREL 101 99 28 48
NYSTATIN 99 93 29 84
FENTANYL 98 93 S2 30 33
LOVASTATIN 98 91 30 53
ZOLPIDEM TARTRATE 97 71 32 21
NEXIUM 90 46 33 39
MELOXICAM 87 83 34 43
MIRTAZAPINE 86 86 35 66
IBUPROFEN 84 56 36 98
AMLODIPINE BESYLATE-BENAZEPRIL 83 83 37 107
GLYBURIDE 82 80 R 38 86
PREDNISONE 79 75 39 51
PLAVIX 76 73 40 75
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 64 40 27
PAROXETINE HCL 75 47 42 65
GLIPIZIDE 71 58 43 70
DIOVAN HCT 69 58 44 181
DOXYCYCLINE HYCLATE 66 60 45 101
DIGOXIN 65 65 46 80
GABAPENTIN 63 53 47 11
ZOSTAVAX 63 55 47 2
LANTUS 62 38 49 35
CELEBREX 62 62 49 195
EXELON 62 62 49 88
POLYETHYLENE GLYCOL 3350 61 60 52 34
ROPINIROLE HCL 61 58 52 69
ATENOLOL 57 46 54 18
LOSARTAN-HYDROCHLOROTHIAZIDE 56 56 55 73
ALPRAZOLAM 56 45 55 209
SULFAMETHOXAZOLE-TRIMETHOPRIM 55 52 57 95
PRAVASTATIN SODIUM 55 47 57 12
TRAZODONE HCL 53 42 59 57
SINGULAIR 53 48 59 121
QUETIAPINE FUMARATE 51 51 61 61
RANITIDINE HCL 51 48 61 26
CYMBALTA 50 29 63 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 2, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.